中国呼吸与危重监护杂志

中国呼吸与危重监护杂志

粒细胞/巨噬细胞集落刺激因子吸入治疗重症肺泡蛋白沉积症一例

查看全文

引用本文: 陈旭萍, 周振兴, 张艺, 成小亮, 郭晓文, 杨丽青, 杨小东. 粒细胞/巨噬细胞集落刺激因子吸入治疗重症肺泡蛋白沉积症一例. 中国呼吸与危重监护杂志, 2018, 17(1): 83-85. doi: 10.7507/1671-6205.201705027 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. 陈露露, 田亚琼, 张英为, 等. 继发于血液系统疾病的肺泡蛋白沉积症三例报告并文献复习. 中国呼吸与危重监护杂志, 2004, 3(1): 34-36.
2. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med, 2003(349): 2527-2539.
3. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med, 1999, 190(6): 875-880.
4. Tanaka T, Motoi N, Tsuchihashi Y, et al. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J Med Genet, 2011, 48(3): 205-209.
5. Campo I, Mariani F, Rodi G, et al. Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis, 2013, 8: 40.
6. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of autoimmune pulmonary alveolar proteinosis patients in Japan. Am J Respir Crit Care Med, 2008, 177(7): 752-762.
7. Ishii H, Trapnell BC, Tazawa R, et al. Comparative study of high resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest, 2009, 136(5): 1348-1355.
8. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med, 2002(166): 215-235.
9. Seymour JF, Dunn AR, Vincent JM, et al. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med, 1996, 335(25): 1924-1925.
10. Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/ macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med, 2010, 181(12): 1345-1354.
11. 詹永忠, 田欣伦, 徐凯峰. 粒细胞巨噬细胞集落刺激因子吸入治疗重症自身免疫性肺泡蛋白沉积症一例. 中国医学科学院学报, 2015, 37(5): 628-630.